Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Growth Horm IGF Res. 2014 Dec 20;25(2):59–65. doi: 10.1016/j.ghir.2014.12.005

Figure 5.

Figure 5

Change in liver fat as measured by MR Spectroscopy (ΔHCL/W%) in the tesamorelin and placebo groups in a 6 month investigation of the effects of tesamorelin on liver fat in HIV-infected subjects with abdominal adiposity (82). Medians with bars for IQR are shown.